ID: ALA4174489

Max Phase: Preclinical

Molecular Formula: C22H29NO5

Molecular Weight: 387.48

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(C(O)CCN2CCc3cc(OC)c(OC)cc3C2)c(OC)c1

Standard InChI:  InChI=1S/C22H29NO5/c1-25-17-5-6-18(20(13-17)26-2)19(24)8-10-23-9-7-15-11-21(27-3)22(28-4)12-16(15)14-23/h5-6,11-13,19,24H,7-10,14H2,1-4H3

Standard InChI Key:  NWFHEKGJBBFSSM-UHFFFAOYSA-N

Associated Targets(Human)

Huh-7 12904 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

KYSE-140 139 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Sigma-1 receptor 3326 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Sigma intracellular receptor 2 922 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 387.48Molecular Weight (Monoisotopic): 387.2046AlogP: 3.20#Rotatable Bonds: 8
Polar Surface Area: 60.39Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.65CX LogP: 2.48CX LogD: 2.04
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.75Np Likeness Score: -0.22

References

1. Sun YT, Wang GF, Yang YQ, Jin F, Wang Y, Xie XY, Mach RH, Huang YS..  (2018)  Synthesis and pharmacological evaluation of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as sigma-2 receptor ligands.,  147  [PMID:29438891] [10.1016/j.ejmech.2017.11.016]

Source